Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(10):1117-1128. doi: 10.1080/14737167.2023.2250916. Epub 2023 Aug 31.
Expert Rev Pharmacoecon Outcomes Res. 2023.
PMID: 37650213
A discrete choice experiment quantified the impact of 7 treatment attributes on VMS treatment choice: VMS frequency/severity reduction, sleep improvement, risk of breast cancer/cardiovascular events in 6 years, risk of short-term side effects, and out-of-pocket costs. Pref …
A discrete choice experiment quantified the impact of 7 treatment attributes on VMS treatment choice: VMS frequency/severity reduction, slee …
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).
Carlson KV, Rovner ES, Nair KV, Deal AS, Kristy RM, Schermer CR.
Carlson KV, et al. Among authors: kristy rm.
Adv Ther. 2019 Aug;36(8):1906-1921. doi: 10.1007/s12325-019-00994-7. Epub 2019 Jun 20.
Adv Ther. 2019.
PMID: 31222714
Free PMC article.
The primary objective was to identify factors associated with improved treatment effectiveness from a patient perspective mainly using the OAB Questionnaire Short-Form (OAB-q SF). The form was sent to patients via email link at baseline and months 1, 3, 6, and 12. ...
The primary objective was to identify factors associated with improved treatment effectiveness from a patient perspective mainly using the O …
Item in Clipboard
Cite
Cite